Study of chromosome 12 copy number in breast cancer using fluorescence in situ hybridization

Cancer Genetics and Cytogenetics

Volumn 108, Issue 1, 1999, Pages 26-31

  Mark, Hon Fong L ^a,b   Brown, Stephen ^a,b   Taylor, William ^a   Bassily, Nader ^a   Sun, Ci Lin ^a   Samy, Mangala ^a   Bland, Kirby I ^a,b  

^a RHODE ISLAND HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CHROMOSOME 12; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; TRISOMY;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 12; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; NEOPLASM STAGING; TRISOMY;

EID: 0032907472     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(98)00104-6     Document Type: Article

References (20)

1. Adeyinka A., Pandis N., Bardi G., Bonaldi L., Mertens F., Mitelman F., Heim S. A subgroup of breast carcinoma is cytogenetically characterized by trisomy 12. Cancer Genet Cytogenet. 97:1997;119-121.
2. Bloom H.J.G., Richardson W.W. Histological grading and prognosis in breast cancer. A study of. 1409(cases of which 359 have been followed for 15 years. Br J Cancer 11):1957;359-377.
3. Pinkel D., Strawne R., Gray J. Cytogenetic analysis using quantitative high sensitivity, fluorescence hybridization. Proc Natl Acad Sci USA. 83:1986;2934-2938.
4. Mark H.F.L. Fluorescent in situ hybridization as an adjunct to conventional cytogenetics. Ann Clin Lab Sci. 24:1994;153-163.
5. Miranda R.N., Mark H.F.L., Medeiros L.J. Fluorescent in situ hybridization in routinely processed bone marrow aspirate clot and core biopsy sections. Am J Pathol. 145:1994;1-6.
6. Afify A., Bland K.I., Mark H.F.L. Fluorescent in situ hybridization assessment of chromosome 8 copy number in breast cancer. Breast Cancer Res Treat. 38:1996;201-208.
7. Afify A., Mark H.F.L. FISH assessment of chromosome 8 copy number in stage I and stage II infiltrating ductal carcinoma of the breast. Cancer Genet Cytogenet. 97:1997;101-105.
8. Mark H.F.L., Grollino M.G., Sulaiman R.A., Lathrop J.C. Fluorescent in situ hybridization (FISH) assessment of chromosome copy number in gestational trophoblastic disease. Ann Clin Lab Sci. 25:1995;291-296.
9. Mark H.F.L., Taylor W., Afify A., Riera D., Rausch M., Huth A., Gray Y., Santoro K., Bland K.I. Stage I and stage II infiltrating ductal carcinoma of the breast analyzed for chromosome 8 copy number using FISH. Pathobiology. 65:1997;184-189.
10. Mark H.F.L., Mills D., Kim E., Santoro K., Quddus M., Lathrop J.C. Fluorescent in situ hybridization assessment of chromosome copy number in buccal mucosal cells. Cytobios. 87:1996;117-126.
11. Mark H.F.L., Mills D., Santoro K., Quddus M., Lathrop J.C. Fluorescent in situ hybridization (FISH) analysis of cervical smears. a pilot study of 20 cases Ann Clin Lab Sci. 27:1997;224-229.
12. Mark H.F.L., Afify A., Taylor W., Santoro K., Lathrop J.C. A subset of gestational trophoblastic disease (GTD) characterized by abnormal chromosome 8 copy number detected by FISH? Cancer Genet Cytogenet. 96:1997;1-6.
13. Mark H.F.L., Huth A., Santoro K., Ferreira K., Barker B. Sequential flow cytometry and FISH for the study of formalin-fixed paraffin-embedded breast cancer tissues. Cancer Genet Cytogenet. 98:1997;1-5.
14. Mark H.F.L., Rehan J., Mark S., Santoro K., Zolnierz K. FISH analysis of single-cell trisomies for determination of clonality. Cancer Genet Cytogenet. 100:1997;1-5.
15. Kim S.Y., Lee J.S., Ro J.Y., Gay M.L., Hong W.K., Hittleman W.N. Interphase cytogenetics in paraffin sections of lung tumors by non-isotopic in situ hybridization. mapping/genotype heterogeneity Am J Pathol. 142:1993;307-317.
16. Hopman A.H.N., Van Hooren E., Van de Kaa C.A., Vooijs P.G.P., Ramaekers F.C.S. Detection of numerical chromosome aberrations using in situ hybridization in paraffin sections of routinely processed bladder cancer. Mod Pathol. 4:1991;503-513.
17. Sandberg A.A., Bridge J.A. The Cytogenetics of Bone and Soft Tissue Tumors. 1994;RG Landes Co, Austin.
18. Kiechle-Schwartz M., Pfeiderer A., Sreekantaiah C., Berger C.S., Medchill M.T., Sandberg A.A. Cluster of trisomy 12 to tumors of the female genitourinary tract. Cancer Genet Cytogenet. 54:1991;273-275.
19. Liang J.C., Kurzrock R., Gutterman J.U., Gallick G.E. Trisomy 12 correlates with elevated expression of p21ras in a human adenosquamous carcinoma of the lung. Cancer Genet Cytogenet. 23:1986;183-188.
20. Dao D.D., Schroeder W.T., Chao L.-Y., Kikuchi H., Strong L.C., Ricardi V.M., Pathak S., Nichols W.W., Lewis W.H., Saunders G.F. Genetic mechanisms of tumor-specific loss of 11p DNA sequences in Wilms' tumor. Am J Hum Genet. 41:1987;202-217.